The Healing Company Inc.

The Healing Company Inc.

HLCO
The Healing Company Inc.US flagOther OTC
0.00
USD
- -
- -
23,278.00Market Cap
The Healing Company Inc.
HLCO
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.18
0.23
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.19
-0.42
-0.35
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.06
-0.16
-0.17
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.19
-0.59
-0.65
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
0.14
-0.14
-0.13
Tangible Book Value per Share
42
44
44
44
44
44
44
44
44
44
44
44
44
44
51
53
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
9
12
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-229.01
-144.16
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-8
-21
-19
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-239.56
-154.43
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
-7
-7
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
-2
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'24
ST Debt
5
5
5
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
53
55
57
Market Capitalization
268
243
93

Working Capital

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'24
Total Current Assets
9
8
7
Cash, Cash Equivalents & STI
3
2
1
Accounts Receivable, Net
1
- -
- -
Inventories
4
3
2
Total Current Liabilities
17
15
14
Payables & Accruals
7
6
6
ST Debt
5
5
5
Deferred Revenue
3
2
2

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-217.74%
-458.33%
-132.07%
Free Cash Flow
316.93%
626.73%
216.77%
Net Income, GAAP
775.08%
1,547.79%
157.85%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
2
3
3
9
2024
3
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.01
-0.01
-0.02
- -
-0.19
2023
-0.16
-0.06
-0.04
- -
-0.42
2024
-0.08
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
The Healing Company Inc. (HLCO) is a health and wellness company that acquires and scales early-stage brands focused on integrated healing, combining conventional medicine with alternative practices such as supplements, nutraceuticals, superfoods, meditation apps, and wellness experiences. The company operates through three segments: e-commerce sales of health and wellness products including mushroom-derived joint, memory, and digestive complexes in capsule form and organic plant-based superfood mixes under the Your Super brand; sales of memberships to its Chopra-branded meditation and wellbeing app; and support for licensed wellness experiences such as retreats offered through partners including CIVANA wellness resort and Lake Nona Performance Club. It serves direct-to-consumer customers and partners primarily in the United States, Europe, and North America, with headquarters in Brooklyn, New York, and founded in 2022. Your Super provides superfood blends in categories such as Detox and Energize, Calm and Clarity, Digest and Reset, Radiance and Vitality, and Balance and Flow, formulated with minimal ingredients and no additives. Chopra offers consumer products, editorial content, social media engagement, and integrative medicine services aimed at holistic wellbeing. The company trades on the OTCQB market and counts investors including Dr. Deepak Chopra, Christian Angermayer, and Steven Bartlett. Recent developments include the 2022 acquisition of leading plant-based superfoods brand Your Super, financed with cash and equity alongside a $150 million credit facility from i80 Group to fuel further growth; the March 2023 acquisition of Chopra Global's wellbeing businesses—including its meditation app, consumer products, and licensed experiences—for $8 million; and up to $7 million in additional funding in 2023 from the Burman family and Goetz Family Office, bringing total equity raised to $17 million to support an acquisition strategy targeting wellness and nutraceutical companies.

Company News

APIChatGPT
  • FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

  • Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

  • FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

  • Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment

  • Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting

  • Luminara Launches to Curate the World's Leading Energy Practitioners for the Digital Age of Healing

  • NurExone's Exosomes Show Stronger Healing Potential Than Industry Standard

  • Billing or Healing? UnitedHealth's HouseCalls Get a DOJ Checkup

  • NETSCOUT Advances AI-Driven Network Operations for TM Forum's NeuroNOC: The Self-Healing Network Brain Catalyst Project

  • U.S. Complementary and Alternative Medicine Market 2025-2030, Featuring Columbia Nutritional, Nordic Nutraceuticals, Ramamani Iyengar Memorial Yoga Institute, The Healing Company, Schumacher Yoga and More

  • AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

  • FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

  • OneMeta Inc. to Provide Real-Time Multilingual Interpretation Technology For Upcoming UCAP Conference for Help, Hope and Healing

  • Direct Energy Invests in Hope and Healing through $60,000 Donation to Two Alberta Hospitals

  • Travel Through Trauma Redefines Healing Through Exploration

  • Inflammatory Disease Healing Data via Palatin's Novel Melanocortin Receptor Agonists Presented at the 19th Annual Peptide Therapeutics Symposium

  • TalkingParents Teams Up with Relationship & Heartbreak Coach to Support Co-Parent Healing

  • Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

  • FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

  • Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024